Antibacterial and anti-inflammatory effects of extracts and fractions from Polygonum capitatum

被引:68
作者
Liao, Shang-Gao [1 ]
Zhang, Li-Juan [1 ]
Sun, Fa [2 ]
Zhang, Jin-Juan [3 ]
Chen, A-Ying [3 ]
Lan, Yan-Yu [1 ]
Li, Yong-Jun [1 ]
Wang, Ai-Min [1 ]
He, Xun [1 ]
Xiong, Ying [3 ]
Dong, Li [1 ]
Chen, Xiao-Jun [1 ]
Li, Yue-Ting [1 ]
Zuo, Li [3 ]
Wang, Yong-Lin [1 ]
机构
[1] Guiyang Med Coll, Sch Pharm, Guiyang 550004, Guizhou, Peoples R China
[2] Guiyang Med Coll, Affiliated Hosp, Dept Urinary Surg, Guiyang 550004, Guizhou, Peoples R China
[3] Guiyang Med Coll, Sch Fundamental Med, Guiyang 550004, Guizhou, Peoples R China
关键词
Polygonum capitatum; Polygonaceae; Active fractions; Antibacterial; Anti-inflammatory;
D O I
10.1016/j.jep.2011.01.050
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Aim of the study: This study was designed to investigate the antibacterial and anti-inflammatory activities of the extracts and the structure-based fractions from P. capitatum so as to provide the evidence for the traditional use of this plant in the treatment of urinary tract infections and to clarify the structural types that were responsible for the clinical use of the plant. Materials and methods: The dry whole plant of P. capitatum was extracted with water and 70% aqueous ethanol and then separated, respectively, into a fraction enriched in polysaccharides and proteins (PP) and four other fractions enriched in gallic acid and its analogues (GM), flavonoids (FV), tannins (TN), and triterpenoids and steroids (TS). UV spectral or chemical methods were used for the confirmation of the five fractions. The in vitro antibacterial activities of the aqueous (AE) and 70% aqueous ethanol (70EE) extracts as well as the fractions against gram-positive and gram-negative bacteria were initially evaluated by a disc diffusion test. The anti-bacterial potencies of the active extracts or fractions were then assessed in vitro by determining the MICs and MBCs. The anti-inflammatory activity was evaluated employing the xylene-induced mouse ear edema model. Results: Except for fraction PP, AE, 70EE, and the four fractions (GAA, FV, TN, and TS) exhibited varying degrees of antibacterial and anti-inflammatory activities. The results of the minimal inhibition concentration (MIC) and minimal bactericidal concentration (MBC) indicated that the crude extracts or fractions FV and TN all possess bacteriostatic and bactericidal properties. Fractions FV and TS showed significantly anti-inflammatory activity (P< 0.01) with the inhibition rates of 86.15 and 73.71% at 0.6 g/kg, respectively, as compared to 76.93% of the positive control dexamethasone. Conclusions: The overall results suggested that the traditional use of this plant for the treatment of urinary tract infections were attributed to the presence of antibacterial and anti-inflammatory agents. The results also provided evidence that the studied plant extracts, as well as some of the fractions obtained from this plant might be potential sources for antimicrobial and anti-inflammatory drug development. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1006 / 1009
页数:4
相关论文
共 13 条
[1]   Spectrum and antibiotic resistance of uropathogens isolated from hospital and community patients with urinary tract infections in two large hospitals in Kuwait [J].
Al Sweih, N ;
Jamal, W ;
Rotimi, VO .
MEDICAL PRINCIPLES AND PRACTICE, 2005, 14 (06) :401-407
[2]  
[Editorial Committee of Chinese Materia Medica State Administration of Traditional Chinese Medicine Editorial Committee of Chinese Materia Medica State Administration of Traditional Chinese Medicine], 2005, ZHONGH BENC, P223
[3]  
Li Y.M., 2007, J GUIZHOU U NAT SCI, V24, P205, DOI [10.3969/j.issn.10005269.2007.02.025, DOI 10.3969/J.ISSN.10005269.2007.02.025]
[4]  
Liu M., 2007, GUIZHOU MED, V31, P370
[5]  
Liu Zhi-Jun, 2008, Zhong Yao Cai, V31, P995
[6]  
Makhmatkulov A. B., 1994, Chemistry of Natural Compounds, V30, P214, DOI 10.1007/BF00630009
[7]  
Ren Guangyou, 1995, Zhongguo Zhongyao Zazhi, V20, P107
[8]  
Wu Q.-J., 1985, CHINESE TRADITIONAL, V16, P5
[9]  
Xu S.Y., 2002, METHODOLOGY PHARM EX, P911
[10]  
XU SY, 2002, METHODOLOGY PHARM EX, P1647